Health
Apoptosis inhibitor enables some lymphomas to resist therapy – Medical Xpress
Lymphomas are a diverse group of cancers of the immune system, which is the body’s primary defense against autoimmune disease, infections, and malignancy. Now, researchers at the University of Tsukuba have clarified risk factors and molecular mechanisms under…
Lymphomas are a diverse group of cancers of the immune system, which is the body’s primary defense against autoimmune disease, infections, and malignancy. Now, researchers at the University of Tsukuba have clarified risk factors and molecular mechanisms underlying primary and adaptive resistance to cancer immunotherapy. This knowledge may inform treatment strategies against aggressive Non-Hodgkin lymphomas (NHL) including Burkitt lymphoma and diffuse large B-cell lymphoma.
One way cancer treatm…
-
General23 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General24 hours agoNSW Waratahs lose Super Rugby Women’s Champions final 36-5 against Auckland Blues in appalling conditions
-
Noosa News23 hours agoHealth experts explain why the jab is critical
-
General8 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?